Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo-Reference-Cited by-同舟云学术

Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo

Published:2012-04-04 Issue:1 Volume:82 Page:47-58
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Zhao Xiao-qin,Xie Jing-dun,Chen Xing-gui,Sim Hong May,Zhang Xu,Liang Yong-ju,Singh Satyakam,Talele Tanaji T.,Sun Yueli,Ambudkar Suresh V.,Chen Zhe-Sheng,Fu Li-wu

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference47 articles.

1. Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects

2. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

3. Controversies in Breast Cancer 2010

4. BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer;Oncogenesis;2024-08-04

2. Peptidylarginine Deiminase 3 Modulates Response to Neratinib in HER2 Positive Breast Cancer;2024-04-22

3. Management and Mechanisms of Diarrhea Induced by Tyrosine Kinase Inhibitors in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer;Cancer Control;2024-01

4. Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2;Drug Resistance Updates;2023-11

5. Neratinib for HER2-positive breast cancer with an overlooked option;Molecular Medicine;2023-10-06